DK477778A - 17alfa-(3-jodbenzoyloxy)-9alfa-4-pregnen-3,20-dioner deres d-homoanaloge og fremgangsmaade til deres fremstilling og deres anvendelse - Google Patents

17alfa-(3-jodbenzoyloxy)-9alfa-4-pregnen-3,20-dioner deres d-homoanaloge og fremgangsmaade til deres fremstilling og deres anvendelse

Info

Publication number
DK477778A
DK477778A DK477778A DK477778A DK477778A DK 477778 A DK477778 A DK 477778A DK 477778 A DK477778 A DK 477778A DK 477778 A DK477778 A DK 477778A DK 477778 A DK477778 A DK 477778A
Authority
DK
Denmark
Prior art keywords
homoanalog
9alfa
dioner
17alfa
pregnen
Prior art date
Application number
DK477778A
Other languages
English (en)
Other versions
DK145666C (da
DK145666B (da
Inventor
U Kerb
M Stahnke
R Wiechert
L Alig
A Fuerst
M Mueller
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772748443 external-priority patent/DE2748443A1/de
Priority claimed from DE2748442A external-priority patent/DE2748442C3/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK477778A publication Critical patent/DK477778A/da
Publication of DK145666B publication Critical patent/DK145666B/da
Application granted granted Critical
Publication of DK145666C publication Critical patent/DK145666C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK477778A 1977-10-26 1978-10-26 Fremgangsmaade til fremstilling af 17alfa-(3-jodbenzoyloxy)-9alfa-chlor-4-pregnen-3,20-dioner eller deres d-homoanaloge DK145666C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2748443 1977-10-26
DE19772748443 DE2748443A1 (de) 1977-10-26 1977-10-26 17alpha-(3-jodbenzoyloxy)-9alpha- chlor-d-homo-4-pregnen-3.20-dione und verfahren zu ihrer herstellung
DE2748442A DE2748442C3 (de) 1977-10-26 1977-10-26 17α-(3-Jodbenzoyloxy)-9α -chlor4-pregnen-3.20-dione, Zwischenprodukte und Verfahren zu ihrer Herstellung, 9α -chlor-17α, 21-dihydroxy-1,4-pregnadien-3,20-dion und dieses enthaltende Arzneimittel
DE2748442 1977-10-26

Publications (3)

Publication Number Publication Date
DK477778A true DK477778A (da) 1979-04-27
DK145666B DK145666B (da) 1983-01-17
DK145666C DK145666C (da) 1983-07-18

Family

ID=25772982

Family Applications (1)

Application Number Title Priority Date Filing Date
DK477778A DK145666C (da) 1977-10-26 1978-10-26 Fremgangsmaade til fremstilling af 17alfa-(3-jodbenzoyloxy)-9alfa-chlor-4-pregnen-3,20-dioner eller deres d-homoanaloge

Country Status (6)

Country Link
EP (1) EP0001737B1 (da)
JP (1) JPS5470253A (da)
BG (1) BG28719A3 (da)
DD (1) DD138981A5 (da)
DK (1) DK145666C (da)
HU (1) HU177759B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252729A (en) * 1978-05-12 1981-02-24 Hoffmann-La Roche Inc. Steroids and process for their manufacture
US4197406A (en) * 1978-05-12 1980-04-08 Hoffmann-La Roche Inc. D-Homosteroids
ES2041245T3 (es) * 1985-10-23 1993-11-16 The Upjohn Company Esteroides angioestaticos.
EP3006453A1 (en) 2014-10-08 2016-04-13 Cosmo Technologies Ltd. 17alpha-monoesters and 17alpha,21-diesters of cortexolone for use in the treatment of tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1081888B (de) * 1956-12-31 1960-05-19 Searle & Co Verfahren zur Herstellung von ?-3-Keto-9 ª‡-halogensteroiden

Also Published As

Publication number Publication date
DK145666C (da) 1983-07-18
JPS5470253A (en) 1979-06-05
DD138981A5 (de) 1979-12-05
HU177759B (en) 1981-12-28
EP0001737B1 (de) 1981-01-07
JPS6227076B2 (da) 1987-06-12
BG28719A3 (en) 1980-06-16
DK145666B (da) 1983-01-17
EP0001737A1 (de) 1979-05-16

Similar Documents

Publication Publication Date Title
DK377678A (da) 3,4,5-trihydroxypiperidinderivater deres fremstilling og anvendelse
DK92378A (da) Substituerede phenoxybenzyloxycarbonylderivater fremgangsmaade til deres femstilling og deres anvendelse som insecticider og acaricider
DK495476A (da) Phenolethere og fremgangsmade til deres fremstilling
NO783471L (no) Xantinderivater og fremgangsmaate til deres fremstilling
NO152975C (no) Glyceroloksydase og fremgangsmaate til fremstilling derav.
DK275178A (da) Fremgangsmaade til fremstilling af lipopeptider og anvendelse deraf
DK557876A (da) Polyhalogensteroider og fremgangsmade til deres fremstilling
DK547378A (da) 1-n-4,6-di-o(aminoglycosyl-)-1,3-dimino-cyclitol-derivater deres fremstilling og anvendelse
DK374177A (da) Fremgangsmaade til deres fremstilling og deres anvendelse som insecticider
DK313878A (da) Indolderivater og fremgangsmaade til fremstilling deraf
NO780800L (no) Azoforbindelser og fremgangsmaate til deres fremstilling
DK409277A (da) Pentapeptider og fremgangsmaade til deres fremstilling
DK582578A (da) 2,4-thiazolidindion-derivater og fremgangsmaade til deres fremstilling
DK375077A (da) Substituerede benzoylureidodiphenylethere fremgangsmaade til deres fremstilling og deres anvendelse som insecticider
DK354777A (da) N-sulfenylerede oximcarbamater fremgangsmade til deres fremstilling og deres anvendelse som insecticider acaricider og nematodicider
DK50677A (da) Thiadiazolylylbenzamider og fremgangsmade til deres fremstilling
DK308878A (da) Aminoglyosidderivater og fremgangsmaader til deres fremstilling
DK111678A (da) Enzym-marumer og fremgangsmaade til deres fremstilling
DK270077A (da) 6,7-benzomorphanderivater og fremgangsmade til deres fremstillling
DK268478A (da) Mercaptoacylamidobenzoylglycin og fremgangsmaade til fremstilling deraf
DK323378A (da) Imidazo-isoquinolin-dioner og fremgangsmaade til deres fremstilling
DK251178A (da) Fremgangsmaade til fremstilling af 9-hydroxyhexahydrodibenzo (b,d)pyraner og 1-substituerede -9-hydroxyhexahydrodibenzo (b,d)pyraner
DK319478A (da) Angiotensinpeptider og deres fremstilling
DK223376A (da) N-benzyl-2,2-dimethoxy-acetamider og fremgangsmade til deres fremstilling
NO784128L (no) Nye tetrapeptider og fremgangsmaate til deres fremstilling

Legal Events

Date Code Title Description
PBP Patent lapsed